41 patents
Utility
Molecular Evidence Platform for Auditable, Continuous Optimization of Variant Interpretation In Genetic and Genomic Testing and Analysis
4 Jan 24
Disclosed herein are system, method, and computer program product embodiments for optimizing the determination of a phenotypic impact of a molecular variant identified in molecular tests, samples, or reports of subjects by way of regularly incorporating, updating, monitoring, validating, selecting, and auditing the best-performing evidence models for the interpretation of molecular variants across a plurality of evidence classes.
Alexandre COLAVIN, Carlos L. ARAYA, Jason A. REUTER
Filed: 14 Sep 23
Utility
Clustering data base on visual model
2 Jan 24
Some embodiments provide a non-transitory machine-readable medium that stores a program.
Kunling Geng
Filed: 3 Dec 19
Utility
Systems and methods for analyzing patient health records
2 Jan 24
Techniques for analyzing patient health records are provided.
Anil Sethi, Peeyush Rai
Filed: 5 Jun 19
Utility
Methods, Systems and Processes of Identifying Genetic Variations
14 Dec 23
Provided herein are novel methods, systems and processes for generating and analyzing sequence data for the determination of the presence or absence of one or more genetic variations within a genome of a subject.
Erik GAFNI, Swaroop ARADHYA, Leah MATZAT, Eric OLIVARES, Vinayak KULKARNI, Joshua PAUL
Filed: 14 Aug 23
Utility
Methods of preparing nucleic acids for sequencing
7 Nov 23
Aspects of the technology disclosed herein relate to methods for preparing and analyzing nucleic acids.
Anthony John Iafrate, Long Phi Le, Zongli Zheng, Jason Myers, Joshua Stahl
Filed: 2 Oct 19
Utility
Methods of nucleic acid sample preparation
24 Oct 23
Aspects of the technology disclosed herein relate to methods of preparing and analyzing nucleic acids.
Joshua Stahl, Jason Myers, Brady Culver, Brian Kudlow
Filed: 2 Jul 20
Utility
Molecular evidence platform for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis
24 Oct 23
Disclosed herein are system, method, and computer program product embodiments for optimizing the determination of a phenotypic impact of a molecular variant identified in molecular tests, samples, or reports of subjects by way of regularly incorporating, updating, monitoring, validating, selecting, and auditing the best-performing evidence models for the interpretation of molecular variants across a plurality of evidence classes.
Alexandre Colavin, Carlos L. Araya, Jason A. Reuter
Filed: 16 Sep 22
Utility
Methods, systems and processes of identifying genetic variations
19 Sep 23
Provided herein are novel methods, systems and processes for generating and analyzing sequence data for the determination of the presence or absence of one or more genetic variations within a genome of a subject.
Erik Gafni, Swaroop Aradhya, Leah Matzat, Eric Olivares, Vinayak Kulkarni, Joshua Paul
Filed: 29 Mar 21
Utility
Sectionizing documents based on visual and language models
15 Aug 23
Some embodiments provide a program that receives a request to sectionize a document, uses a visual model to identify a set of candidate section headers in the document, and uses a language model to determine a type of section header for at least one candidate section header in the set of candidate section headers in the document.
Kunling Geng
Filed: 1 Apr 22
Utility
Molecular Evidence Platform for Auditable, Continuous Optimization of Variant Interpretation In Genetic and Genomic Testing and Analysis
20 Apr 23
Disclosed herein are system, method, and computer program product embodiments for optimizing the determination of a phenotypic impact of a molecular variant identified in molecular tests, samples, or reports of subjects by way of regularly incorporating, updating, monitoring, validating, selecting, and auditing the best-performing evidence models for the interpretation of molecular variants across a plurality of evidence classes.
Alexandre COLAVIN, Carlos L. ARAYA, Jason A. REUTER
Filed: 16 Sep 22
Utility
Methods, systems and processes of identifying genetic variation in highly similar genes
21 Mar 23
Provided herein are novel methods, systems and processes for mapping sequence reads to a modified reference genome and determining the presence or absence of a genetic variation, or the likelihood thereof, in a gene of interest in a subject.
Daniel J. Kvitek, Erik Gafni
Filed: 9 Jul 19
Utility
Sequence Assembly
5 Jan 23
The invention relates to assembly of sequence reads.
Gregory PORRECA, Caleb KENNEDY
Filed: 18 Jul 22
Utility
Assays for Single Molecule Detection and Use Thereof
27 Oct 22
The invention relates to methods of detecting a genetic variation in a genetic sample from a subject using labeled probes and counting the number of labels in the probes.
Adrian Nielsen Fehr, Patrick Kames Collins, Jill Lyndon Herschleb, Hywel Bowden Jones
Filed: 9 May 22
Utility
Recognizing entities based on word embeddings
4 Oct 22
Some embodiments provide a non-transitory machine-readable medium that stores a program.
Gokhuldass Mohandas
Filed: 9 Sep 19
Utility
Molecular evidence platform for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis
4 Oct 22
Disclosed herein are system, method, and computer program product embodiments for optimizing the determination of a phenotypic impact of a molecular variant identified in molecular tests, samples, or reports of subjects by way of regularly incorporating, updating, monitoring, validating, selecting, and auditing the best-performing evidence models for the interpretation of molecular variants across a plurality of evidence classes.
Alexandre Colavin, Carlos L. Araya, Jason A. Reuter
Filed: 17 Oct 18
Utility
Systems and Methods for Single Molecule Quantification
22 Sep 22
A method for quantifying labels on a substrate is performed by an electronic device with one or more processors and memory.
Hywel Bowden Jones, Andrea Lynn McEvoy
Filed: 14 Jan 22
Utility
Systems and Methods for Quantification and Presentation of Medical Risk Arising from Unknown Factors
15 Sep 22
Example methods of quantifying known and unknown risks of an adverse drug event in an individual based on various factors are disclosed.
Howard C. COLEMAN, Robert D. Patterson, Jessica Oesterheld, Rajeev V. Pany, Kristine Ashcraft
Filed: 8 Apr 22
Utility
Methods of Nucleic Acid Sample Preparation
8 Sep 22
Aspects of the technology disclosed herein relate to methods of preparing and analyzing nucleic acids, e.g., cfDNA, and nucleic acids encoding immune receptors and immunoglobulins.
Joshua Stahl, Jason Myers, Brady Culver, Brian Kudlow, Jens Eberlein
Filed: 17 May 22
Utility
Sectionalizing clinical documents
23 Aug 22
Techniques for sectionalizing clinical documents are provided.
Peeyush Rai
Filed: 9 Sep 19
Utility
Sectionizing Documents Based on Visual and Language Models
21 Jul 22
Some embodiments provide a program that receives a request to sectionize a document, uses a visual model to identify a set of candidate section headers in the document, and uses a language model to determine a type of section header for at least one candidate section header in the set of candidate section headers in the document.
Kunling GENG
Filed: 1 Apr 22